Background: : Lichen plan pigmentosus (LPP) is a cosmetically distressing pigmentation disorder that is often challenging to treat. Despite the limited availability of effective therapeutic options, tranexamic acid (TXA) and oral retinoids have emerged as promising treatments. This study evaluates the efficacy and safety of TXA and/or oral retinoids in patients with LPP. Materials and Methods: : We included 39 patients, with predominant sun exposure. Patients were treated locally with topical agents, and some received laser therapy. Systemic treatments (TXA and/or oral retinoids) were administered to certain patients, and therapeutic outcomes were assessed. Results: Moderate to good improvements were observed in more than half of the patients, particularly those treated with combined low-dose retinoids and TXA. The side effects were minor and did not require treatment discontinuation. Conclusion: This study, suggests that TXA and oral retinoids could be effective treatments for LPP. However, larger trials are needed to confirm these findings and improve treatment options for this condition. Key words: Lichen pigmentosus, tranexamic acid, isotretinoin, systemic therapy
Localized cutaneous scleroderma, or morphea, is a highly heterogeneous group of autoimmune disorders that primarily affect the skin and adjacent tissues. Its pathogenesis remains unclear. Numerous factors, including genetics, drugs, infections, skin injuries, autoimmune diseases with abnormal cytokine production and/or such as vascular dysfunction, may play a role in the development of morphea. Fibrosis, inflammation, and chronic ulceration may ultimately contribute to skin neoplasia. Herein, we report a case of multiple metastatic squamous cell carcinomas complicating cocaine-induced morphea. Key words: Squamous cell carcinoma, Induced scleroderma, Morphea, Drugs, Cocaine